Use DEXA (dual energy X-ray absorptiometry) for osteoporosis screening, says CDC (US Centers for Disease Control and Prevention)
This article was originally published in Clinica
A report by the US Centers for Disease Control and Prevention (CDC) has confirmed that dual energy X-ray absorptiometry (DEXA) is "the best tool available" to diagnose women who are at high risk of osteoporosis.
You may also be interested in...
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.
Alvotech has struck a major deal with Yangtze River Pharmaceutical that will allow eight of the biosimilars developer’s products to be commercialized in China.